Recursion and Exscientia, two pioneers in artificial intelligence (AI)-based drug development, have completed a business combination that they vowed will enhance their ability to carry out drug ...
Abstract: Narrow passage scenarios pose significant challenges for path planning, especially for tasks requiring real-time performance. Traditional asymptotically converging sampling-based planners ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results